[reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed t]
[] [Equity Transfer Agreement Transferor：Zhejiang Kandi Vehicles Co., Ltd. Transferee: Geely Technology Group Co., Ltd. After friendly consultation between the transferor and the transferee, the following agreements have been signed with respect to the transfer of the transferor's equity in Kandi Ele]
[Hong Kong Listing Rules By order of the Board China Southern Airlines Company Limited Xie Bing Company Secretary Guangzhou, the Peoples Republic of China 9 May 2019 non-executive As at the date of this announcement, the Directors include Wang Chang Shun, Ma Xu Lun and Han Wen Sheng as executive Dir]
[] [Equity Transfer Agreement Transferor：Zhejiang Kandi Vehicles Co., Ltd. Transferee: Geely Technology Group Co., Ltd. After friendly consultation between the transferor and the transferee, the following agreements have been signed with respect to the transfer of the transferor's equity in Kandi Ele]
[Hong Kong Listing Rules By order of the Board China Southern Airlines Company Limited Xie Bing Company Secretary Guangzhou, the Peoples Republic of China 9 May 2019 non-executive As at the date of this announcement, the Directors include Wang Chang Shun, Ma Xu Lun and Han Wen Sheng as executive Dir]
[FOR RELEASE May 10, 2019 China Biologic Reports Financial Results for the First Quarter of 2019 —1Q19 Total Sales Up 15.4% YoY in USD terms, or 22.3% YoY in RMB terms; Net Income Up 19.3% YoY to $37.7 Million; Non-GAAP Adjusted Net Income Up 14.3% YoY in RMB terms — BEIJING, China – May 10, 2019 – F]
[Kandi Technologies Reports First Quarter 2019 Financial Results -Q1 revenue increased 116.8% YoY to $18.1 million - Q1 off-road vehicles sales increased 169.8% YoY to $5.3 million -Q1 gross margin increased to 17.4% compared to 16.1% Kandi Technologies Group, Inc. JINHUA, CHINA--(May 10, 2019) - Fir]
[FOR RELEASE May 10, 2019 China Biologic Reports Financial Results for the First Quarter of 2019 —1Q19 Total Sales Up 15.4% YoY in USD terms, or 22.3% YoY in RMB terms; Net Income Up 19.3% YoY to $37.7 Million; Non-GAAP Adjusted Net Income Up 14.3% YoY in RMB terms — BEIJING, China – May 10, 2019 – F]
[Kandi Technologies Reports First Quarter 2019 Financial Results -Q1 revenue increased 116.8% YoY to $18.1 million - Q1 off-road vehicles sales increased 169.8% YoY to $5.3 million -Q1 gross margin increased to 17.4% compared to 16.1% Kandi Technologies Group, Inc. JINHUA, CHINA--(May 10, 2019) - Fir]
